Order byBest matchMost fresh

Covid-19, FDA and vaccine

Digest more
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 infection.

Continue reading

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
MedPage Today · 43m
FDA Panel to Consider COVID Vaccine Makeup for Next Season
US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant
The U.S. Senate plans to vote this week to bar California's landmark plan to end the sale of gasoline-only vehicles by 2035 that has been adopted by 11 other states, Majority Leader John Thune said on...

Continue reading

F.D.A. Poised to Restrict Access to Covid Vaccines
Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved
FDA sets new COVID booster guidelines for healthy adults under 65
Vaccine makers have argued that because COVID vaccines have been changed annually to match the circulating strain of the virus, new placebo-controlled trials could delay availability of the shots unt...

Continue reading

FDA to limit future Covid-19 shots to older people and those at risk of serious infection
Las Vegas Sun · 12h
RFK Jr. pledged not to upend US vaccine system, but big changes are underway
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.
FDA to Unveil Covid Shot Policy as RFK Jr. Eyes More Tests
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.
Explore more
Feedback